治疗惯性与初始低剂量四重组合治疗高血压:四重试验的结果
Nelson Wang1,2,3, Amy Von Huben4, Simone Marschner5
1The George Institute for Global Health, UNSW Sydney (N.W., A.R., T.U., J.C., E.R.A., L.B.).
Hypertension (Dallas, Tex. : 1979)
|March 13, 2024
概括
与初始单疗法相比,超低剂量四倍药 (Quadpill) 显著降低了治疗惯性,定义为缺乏血压 (BP) 治疗强化,与初始单疗法相比. 这突显了Quadpill在改善血压管理和克服治疗延迟方面的潜力.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 低剂量组合疗法显示出改善血压 (BP) 控制的前景.
- 这些组合对治疗惯性的影响仍然不确定.
研究的目的:
- 为了比较超低剂量四重药 (Quadpill) 方案和初始单疗法之间的治疗惯性事件的频率.
- 分析高血压患者治疗加剧的决定因素.
主要方法:
- 一个随机试验,涉及591名患者,将Quadpill与初始单一疗法进行比较.
- 治疗惯性被定义为血压>140/90 mmHg的访问,而没有加强治疗.
- 分析使用治疗意图和不受控制的BP分母进行.
主要成果:
- 与单疗法相比,接受Quadpill的参与者治疗惯性较少 (11%与6个月后23%相比,P=0.002).
- 在那些没有控制血压的人中,治疗惯性率在两组之间是相似的 (P>0.4).
- 不加强治疗的主要原因包括接近目标的血压读数和显著的血压改善.
结论:
- 与初始单疗法相比,超低剂量四片剂减少了治疗惯性事件.
- 尽管情况有所改善,但在第一次随访后,治疗强化在两组中都经常被推迟.
- 提高患者和临床医生的教育对于及时加强治疗至关重要,即使接近目标血压或显著降低血压.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
428
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
428
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
164
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
164
01:28Drug Therapy
43
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
43
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
726
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
726
01:25Antihypertensive Drugs: Direct Renin Inhibitors
621
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
621
01:15Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
61
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
61